Available GLP-1s include semaglutide (Ozempic/Wegovy active ingredient) and tirzepatide (Mounjaro/Zepbound active ingredient, also targets GIP receptors)
Administration: Taken orally, this form is designed to protect glutathione from digestive enzymes, enhancing absorption
While individual cases of increased suicidality following GLP-1 receptor agonist use have been reported, our large cohort study found no such association and instead suggested a decreased risk of suicidal behavior in adolescents receiving this treatment, Kerem told Healio
[1] Patients should be counseled to immediately report severe, persistent abdominal pain radiating to the back, as this may indicate pancreatitis requiring treatment discontinuation and urgent evaluation
For many, this unpredictability leads to frustration, panic, or a sense that the medication "isnt working." Early in treatment, those shifts can feel especially discouraging
Do not spray Ryaltris into your eyes or mouth